Clinical and Histological Characterization of Toxic Keratopathy From Depatuxizumab Mafodotin (ABT-414), an Antibody-Drug Conjugate: [RETRACTED].
Sign Up to like & getrecommendations! Published in 2018 at "Cornea"
DOI: 10.1097/ico.0000000000001635
Abstract: PURPOSE To report the first histological characterization of microcyst-like epithelial keratopathy (MEK) associated with depatuxizumab mafodotin (ABT-414). METHODS Case report. RESULTS A 35-year-old man with glioblastoma multiforme participating in a phase III trial of the… read more here.
Keywords: depatuxizumab mafodotin; mafodotin abt; histological characterization; abt 414 ... See more keywords